A 'glacial outburst' prompted a flooding crisis in Alaska. What is that?
On Aug. 13, emergency barriers protecting Juneau appear to be holding, but the risk from summer glacial flooding is on the rise as climate change increases temperatures, causing more ice melt.
Glacial lake outburst flooding is a flood that's produced by the quick, unexpected release of water from a glacial lake.
These lakes can exist behind unsteady dams made of ice or bedrock, and when these dams fail, the water rushes out, often resulting in catastrophic downstream flooding.
A glacial outburst like the one in Alaska this week occurs when an ice dam holding back a lake – in this case Suicide Basin – collapses amid summer heat, releasing the water in a short period of time. Suicide Basin is part of the Mendenhall Glacier.
Aaron Jacobs, a hydrologist at the National Weather Service office in Juneau, said that as these events continue to unfold, scientists need to continue to improve their understanding of these glacial systems, especially as the climate continues to change and warm throughout Alaska.
Previous studies have tied glacier loss with climate change
Thanks to climate change, Earth's glaciers continue to melt away, losing up to 390 billion tons of ice and snow per year, a 2019 study said. The largest losses were glaciers in Alaska.
And a 2014 study found that since 1990, humans have been the primary cause of melting glaciers worldwide. In that study, researchers found that, from 1990 to 2010, about two-thirds of the world's glacier loss was due to rising temperatures from the burning of greenhouse gases, along with land-use changes.
"In our data we find unambiguous evidence of anthropogenic (human-caused) contribution to glacier mass loss," said study lead author Ben Marzeion, a climate scientist at the University of Innsbruck in Austria.
A 2023 study also found that millions of people worldwide are at risk of glacial lake outburst flooding, primarily in Asia.
Glacial outburst floods on the rise amid climate change
These glacial outbursts in Alaska are not a new phenomena and have been occurring annually in the Suicide Basin, sometimes more than once, since 2011. What is new in the last few years is the amount of water being released all at once during these events, which led to back-to-back years of record flooding downstream in Juneau in 2023 and 2024, according to the National Oceanic and Atmospheric Administration.
Compared to the rest of the country, Alaska has warmed twice as fast over the last several decades, and its average annual temperature has risen 3.1 degrees Fahrenheit in the past century, according to the federal National Centers for Environmental Information.
In other parts of the world, glacial outburst floods are also known as Jökulhlaups (an Icelandic word pronounced yo-KOOL-lahp), according to the National Park Service.
This article originally appeared on USA TODAY: What is a 'glacial outburst'? Juneau, Alaska flooding fears explained.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
27 minutes ago
- CNET
Ultrahuman Calls Ring Air the World's Most Accurate Ovulation-Tracking Smart Ring After New Acquisition
Ultrahuman has taken an algorithm designed for intravaginal fertility monitors and transformed it into a non-invasive, temperature-sensing feature that can track your cycle right from your finger. The wearable health tech company announced today that it acquired viO HealthTech, which created the OvuSense algorithm. Validated in 13 peer-reviewed clinical publications and backed by 15 years of clinical research, the algorithm draws on data from over 260,000 cycles collected with medical-grade sensors. It was previously used in class II intravaginal medical fertility monitors. Now, Ultrahuman has adapted that technology for wellness tracking to create its Cycle and Ovulation Pro PowerPlug for the Ring Air. In a press release, Ultrahuman said Cycle and Ovulation Pro delivers over 90% accuracy in confirming ovulation -- a level the company says makes the Air the "world's most accurate cycle-tracking smart ring." This data comes from equivalence testing that compared OvuSense and Ring AIR with a multi-hormone ovulation prediction method that tracks rises in luteinizing hormone and progesterone. Though other cycle trackers may report different ovulation confirmation rates -- for example, the Oura Ring claims 96.4% -- that data isn't directly comparable to OvuSense and Ring Air's testing due to differences in validation protocols, datasets and definitions of detection. Ultrahuman Most platforms that track menstrual cycles rely on a 28-day cycle, but Cycle and Ovulation Pro takes into consideration that 87% of people who menstruate have varying cycles due to conditions such as polycystic ovary syndrome, endometriosis, non-bleeding, thyroid disorders or irregular bleeding. "This collaboration benefits from 15 years of clinically proven women's health expertise and applies it to the world's lightest smart ring," said Mohit Kumar, Ultrahuman CEO, in the press release. "For the first time, best-in-class hardware, software and algorithms with a clinical background come together in one wellness device. Our mission is to give women cutting-edge tools to optimize their health, combining clinical technology with comfort and style to deliver the most accurate women's health tool available." Cycle and Ovulation Pro complements Ultrahuman Ring Air's existing free Cycle and Ovulation PowerPlug, which provides basic conception and cycle tracking. Using physiological patterns and temperature biomarkers passively captured by the smart ring, the Pro version can support fertility planning, offer a space for mood, symptom and behavior logging and use temperature data to suggest hidden patterns in a cycle. Known as Cycle Flags, these patterns may include early, late or absent ovulation, a short luteal phase and trends potentially linked to conditions such as PCOS or miscarriage risk. Ultrahuman While the OvuSense algorithm is FDA-cleared for intravaginal use, the adapted, non-invasive version for the Ultrahuman Ring Air was created for general wellness and isn't FDA-cleared. In other words, the Ring Air isn't a substitute for contraception or for professional medical diagnosis and treatment. For those, you should consult your health care provider. How much does Ultrahuman's Cycle and Ovulation Pro cost? Now available in the US, UK, EU, Australia and Canada, Cycle and Ovulation Pro is a premium PowerPlug in the Ultrahuman app that costs $3.99 per month or $39.99 per year. The current Cycle and Ovulation PowerPlug remains free.
Health Line
36 minutes ago
- Health Line
Do GLP-1 Weight-Loss Drugs Cause Vision Loss? What to Know
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent. People should be aware of potential eye disease and blindness risks when discussing a GLP-1 with their doctor. The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues. Scientists have been closely studying this association as more people turn to these widely prescribed drugs for weight management. Some studies have suggested a link, but the overall evidence has been inconsistent. However, when a potential side effect becomes as serious as vision loss or blindness, even a remote possibility is worth investigating. GLP-1 drugs are a class of medications used to treat obesity and type 2 diabetes that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). They work by mimicking naturally occurring hormones that help regulate blood sugar, promote satiety, and reduce appetite. While GLP-1s are generally well tolerated and offer numerous health benefits — from weight loss and better glucose control to a lower risk of cardiovascular disease — research suggests they could increase the risk of certain serious eye conditions. Previous research has linked GLP-1 drugs to a sudden, vision-threatening condition called nonarteritic anterior ischemic optic neuropathy (NAION) and to 'wet' age-related macular degeneration. The risk of developing these conditions is relatively low. However, they are serious and should be factored into the risk–benefit discussion when considering GLP-1 therapy with a doctor. As a flurry of new research offers a clearer picture of how GLP-1 drugs may affect eye health, Healthline spoke with experts to help break down the findings. GLP-1 drugs and eye disease Three new studies investigated the link between GLP-1s and eye disease, but each employed distinct methods and arrived at different conclusions. A new study compared the effects of semaglutide or tirzepatide with other antidiabetic medications — such as insulin and metformin — on optic nerve conditions, including NAION, in patients with type 2 diabetes. The retrospective cohort study, published on August 11 in JAMA Network Open, included nearly 160,000 patients, evenly split into two groups: one taking GLP-1s and one taking other antidiabetic medications. Over two years of follow-up, those taking a GLP-1 had higher rates of NAION and other optic nerve conditions than those in the comparison group. There were 93 patients with other optic nerve disorders in the semaglutide or tirzepatide group, and 54 patients with these disorders in the comparison group. The study did not specify the types of other optic nerve disorders. 'Newer GLP-1RAs have lots of benefits. This study provides evidence of their potential risks. For each patient, the risk-benefit tradeoff critically depends on a patient's clinical characteristics and their preferences and clinicians' recommendations,' senior study author Rong Xu, PhD, professor and director of the Center for AI in Drug Discovery at Case Western Reserve University, told Healthline. A separate retrospective study, also published in August in the same journal, reached a different conclusion. In a large cohort of patients with type 2 diabetes, researchers found that GLP-1 use was not associated with a higher incidence of NAION but was linked to another eye condition: diabetic retinopathy. During a two-year follow-up, 5,037 patients taking a GLP-1 developed diabetic retinopathy, compared with 4,938 who were not — a 7% increased risk. In a twist, the study found that although there was a small increase in diabetic retinopathy, GLP-1 use appeared to protect against the condition's progression and sight-threatening complications. A subgroup of patients in the study had pre-existing diabetic retinopathy. Those who took a GLP-1 had a lower risk of complications, including progression to proliferative diabetic retinopathy, diabetic macular edema, vitreous hemorrhage, and neovascular glaucoma. They were also less likely to require medical, surgical, or laser treatments for their eyes. Most notably, GLP-1 use was associated with a significantly lower incidence of blindness from any cause. Another study — a meta-analysis and review of 78 trials involving more than 73,000 participants — concluded that semaglutide was associated with an increased incidence of NAION but emphasized that evidence for a causal link remains inconclusive. The review, published on August 14 in JAMA Ophthalmology, found that semaglutide neither increased nor reduced the risk of eye disorders, including diabetic retinopathy. It's important to note that all three studies can only identify correlations and cannot establish that taking a GLP-1 causes these eye disorders. Studies so far have also focused almost exclusively on patients with type 2 diabetes, so it's unclear what effect GLP-1s have on eye conditions in individuals taking them for weight loss. Making sense of GLP-1s and eye health If you're having trouble making sense of what these conflicting findings mean — especially if you already take a GLP-1 or are considering one — you're not alone. Here's a quick summary on GLP-1s and various eye conditions, and what experts have to say about them: NAION NAION causes sudden blindness in one eye, usually after waking, that is caused by a lack of blood flow to the optic nerve. The condition is elusive, and not well understood. The condition is serious, but despite an apparent increased incidence among patients taking GLP-1s, the condition is still uncommon. 'NAION is rare in general,' said Xu. 'For patients with high risk of developing NAION (e.g., those with diabetes, hypertension) who are taking GLP-1RAs, ophthalmologists may increase vigilance,' she said. Linda Lam, MD, MBA, an ophthalmologist with Keck Medicine of USC, who wasn't involved in the research, tells Healthline that it's too early to make a 'definitive connection' between NAION and GLP-1s. 'To make a correlation that GLP-1s cause NAION would be a big leap,' she said. Diabetic retinopathy Diabetic retinopathy is a complication of type 1 and type 2 diabetes that may lead to vision loss. It is the most common cause of preventable blindness in the United States. Though it may seem counterintuitive, antidiabetic medications that improve blood glucose may worsen this condition. 'It's better to be cautious and protective with vision. So, if a patient has started on a GLP-1 and they already have some diabetic retinopathy, I would just have them come in sooner to see their eye care provider,' said Lam. 'Wet' age-related macular degeneration A recent study published in June found that patients with type 2 diabetes who took GLP-1s were more than twice as likely to develop wet AMD as those who did not. Researchers also identified a dose response, meaning that the longer the patients took a GLP-1, the more likely they were to develop the condition. However, there still needs to be more research to substantiate this link. 'We need to have a lot more studies before we can make these cause and effect determinations. But, anyone who has neovascular AMD and is on a GLP-1 needs to be monitored more closely,' said Lam. The bottom line: GLP-1s have many health benefits, and while there is some evidence to support an association between them and serious eye conditions, that link should not be overstated, and must be considered within the greater context of your individual health. Patients with diabetes should get regular eye exams, regardless of whether they are taking a GLP-1, but taking the medication may be one more reason to schedule an exam. 'GLP-1s have potentially good long-term effects for long-term health in patients with diabetes or obesity. But doctors should be much more cautious and aware of visual complications while they're on these medications, especially when their glycemic numbers go down rapidly. The threshold for when to see your eye care provider or retina specialist should be lower,' Lam said.
Yahoo
an hour ago
- Yahoo
What would Mars look like in daylight? 'Enhanced' photo from Perseverance offers a look
With its reddish-hued surface and surroundings, Mars has more than earned its colorful nickname. But how would the Red Planet appear under clear-blue Earth skies? Thanks to a NASA rover wandering the Martian iron oxide-infused surface, we now have a rough idea. Perseverance, one of two car-sized robotic rovers managed from NASA's Jet Propulsion Laboratory in Southern California, has spent years exploring the Mars surface for signs that the planet was once habitable. Scientists believe the geology of Mars may hold valuable clues about past ancient life, and so the robotic vehicles, controlled remotely from Earth, have slowly navigated the rocky terrain to scoop up and collect intriguing samples. Along the way, Perseverance has made some extraordinary finds and captured some stunning vistas. The latest came earlier in May, when the rover captured what NASA described as "one of the sharpest panoramas of its mission so far." NASA released the mosaic in August, which, with color-enhancing technology, unveils the Martian landscape under a sky that is "deceptively" blue. Perseverance: Object resembling a helmet spotted on Mars surface by rover What is Perseverance? What to know about NASA rover In July 2020, the Perseverance rover underwent a 200-day, 300-million-mile journey to reach Mars. After landing in February 2021 in the Jezero Crater, the robot, controlled remotely from Earth, spent nearly four years searching for and collecting more than two dozen rock samples – many of which are stored at the first-ever depot on another planet for future retrieval. The bottom of the Jezero Crater – believed to have formed 3.9 billion years ago from a massive impact – is considered to be among the most promising areas on Mars to search for evidence of ancient life. Perseverance's adventures have revealed some insights about the enigmatic Martian geology. Then in 2024, after years in the trenches of Jezero, Perseverance in December finally summitted the steep Martian crater to begin the next leg of its journey exploring the crater's rim. The rocks Perseverance has spent years collecting are of high interest to NASA and the European Space Agency, which hopes to one day soon retrieve the samples and bring them back to Earth before humans themselves venture to the Red Planet. NASA's Curiosity rover has also been exploring the Martian surface since 2012 in the Gale Crater. 'Enhanced-color' photo shows Mars under Earth-like skies The imaging team of NASA's Perseverance Mars rover took advantage of clear skies May 26 on the Red Planet to capture the recent panoramic image from the rover's Mastcam-Z camera. The final product, a 360-degree panorama of an area nicknamed "Falbreen," was stitched together from 96 separate images. One version shows Mars in all its natural rust-colored glory. The other mosaic is what NASA refers to as an "enhanced-color" version that had its color bands processed to "improve visual contrast and accentuate color differences," NASA said in a press release. The result? A Martian sky that more accurately resembles Earth's. "In this particular mosaic, we have enhanced the color contrast, which accentuates the differences in the terrain and sky," Jim Bell, Mastcam-Z's principal investigator at Arizona State University in Tempe, said in a statement. Several interesting features are visible in the image, including a rock that appears to lie on top of a sand ripple and hills as distant as 40 miles away. Tracks from the rover's journey to the location can also be seen toward the mosaic's right edge about 300 feet away. Martian 'helmet' and other recent rover discoveries The panoramic photo is just one of several recent sights and discoveries made possible by Perseverance in 2025. Earlier in August, NASA published a photo of a rock on the surface of Mars with a pointed peak and a flared "brim" resembling a centuries-old helmet. The image, taken Aug. 5 by the rover's Left Mastcam-Z camera, was chosen as the photo of the week for week 234 of its mission on Mars. Perseverance also made two incredible finds earlier in the year, the most recent of which occurred in March when the rover came across an oddly textured rock comprised of hundreds of millimeter-sized spheres. In January, Perseverance also witnessed a relatively uncommon sight of two dust devils swirling and spinning near one another. NASA released the video and imagery of the phenomenon in April. Contributing: James Powel, USA TODAY Eric Lagatta is the Space Connect reporter for the USA TODAY Network. Reach him at elagatta@ This article originally appeared on USA TODAY: Mars daylight skies photos show new NASA rover views
